Доброкачественная метастазирующая лейомиома: обзор литературы

В обзоре систематизированы данные о патогенезе, клиническом течении и терапии доброкачественной метастази рующей лейомиомы. Доброкачественная метастазирующая лейомиома – редкое заболевание, встречающееся у женщин репродуктивного возраста, характеризуется развитием множественных доброкачественных гладкомы шечных митотически неактивных опухолей (метастазов) внематочной локализации с индолентным течением при наличии лейомиомы матки в анамнезе и отсутствии данных, указывающих на иной опухолевый процесс. Пред ставлена в различных формах: перитонеальный лейомиоматоз, интравенозный лейомиоматоз, поражение паренхиматозных органов, костей, скелетных мышц. В настоящее время отсутствуют стандарты лечения больных добро качественной метастазирующей лейомиомой. Тактика зависит от локализации метастазов и клинических проявлений заболевания: динамическое наблюдение, гормонотерапия, хирургическое лечение.

1. Адамян Л.В., Андреева Е.Н., Артымук Н.В. и др. Миома матки: диагностика, лечение и реабилитация. Клинические рекомендации по ведению больных. Москва: Изд-во Научного центра акушерства, гинекологии и перинатологии им. В.И. Кулакова, 2015.

2. Печетов А.А., Леднев А.Н., Ратникова Н.К., Волчанский Д.А. Доброкачественная метастазирующая лейомиома матки с поражением легких: проблемы диагностики и лечения. Хирургия. Журнал им. Н.И. Пирогова 2020;(9):85–8.

3. Steiner P.E. Metastasizing fibroleiomyoma of the uterus: Report of a case and review of the literature. Am J Pathol 1939;15(1):89–110.7.

4. Robboy S.J., Bentley R.C., Butnor K., Anderson M.C. Pathology and pathophysiology of uterine smooth-muscle tumors. Environ Health Perspect 2000;108(Suppl 5):779–84. DOI: 10.1289/ehp.00108s5779

5. Савостикова М.В., Левченко Н.Е., Лактионов К.П. и др. Мезенхимальные опухоли тела матки. Онкогинекология 2014;(3):11–22.

6. Awonuga A.O., Rotas M., Imudia A.N. et al. Recurrent benign metastasizing leiomyoma after hysterectomy and bilateral salpingo oophorectomy. Arch Gynecol Obstet 2008;278:373–6.

7. Al-Talib A., Tulandi T. Pathophysiology and possible iatrogenic cause of leiomyomatosis peritonealis disseminata. Gynecol Obstet Invest 2010;69(4):239–4.

8. Abell M.R., Littler E.R. Benign metastasizing uterine leiomyoma. Multiple lymph nodal metastases. Cancer 1975;36(6):2206–13.

9. Taubert H.D., Wissner S.E., Haskins A.L. Leiomyomatosis peritonealis disseminata: An unusual complication of genital leiomyomata. Obstet Gynecol 1965;25:561–74.

10. Danikas D., Goudas V.T., Rao C.V., Brief D.K. Luteinizing hormone receptor expression in leiomyomatosis peritonealis disseminata. Obstet Gynecol 2000;95(6 Pt 2):1009–11.

11. Nucci M.R., Drapkin R., Dal Cin P. et al. Distinctive cytogenetic profile in benign metastasizing leiomyoma: Pathogenetic implications. Am J Surg Pathol 2007;31(5):737–43.

12. Rivera J.A., Christopoulos S., Small D., Trifiro M. Hormonal manipulation of benign metastasizing leiomyomas: Report of two cases and review of the literature. J Clin Endocrinol Metab 2004;89(7):3183–8. DOI: 10.1210/jc.2003-032021

13. Bekkers R.L., Willemsen W.N., Schijf C.P. et al. Leiomyomatosis peritonealis disseminata: Does malignant transformation occur? A literature review. Gynecol Oncol 1999.

14. Herrero J., Kamali P., Kirschbaum M. Leiomyomatosis peritonealis disseminata associated with endometriosis: A case report and literature review. Eur J Obstet Gynecol Reprod Biol 1998;76(2):189–91.

15. Hoynck van Papendrecht H.P., Gratama S. Leiomyomatosis peritonealis disseminata. Eur J Obstet Gynecol Reprod Biol 1983;14(4):251–9.

16. Arai T., Yasuda Y., Takaya T., Shibayama M. Natural decrease of benign metastasizing leiomyoma. Chest 2000;117(3):921–2.

17. Egberts J.H., Schafmayer C., Bauerschlag D.O. et al. Benign abdominal and pulmonary metastasizing leiomyoma of the uterus. Arch Gynecol Obstet 2006;274(5):319–22.

18. Wentling G.K., Sevin B.U., Geiger X.J., Bridges M.D. Benign metastasizing leiomyoma responsive to megestrol: Case report and review of the literature. Int J Gynecol Cancer 2005;15:1213–7.

19. Funakoshi Y., Sawabata N., Takeda S. et al. Pulmonary benign metastasizing leiomyoma from the uterus in a postmenopausal woman: Report of a case. Surg Today 2004;34(1):55–7.

20. Fan R., Feng F., Yang H. et al. Pulmonary benign metastasizing leiomyomas: A case series of 23 patients at a single facility. BMC Pulm Med 2020;20(1):292.

21. Barnaś E., Książek M., Raś R. et al. Benign metastasizing leiomyoma: A review of current literature in respect to the time and type of previous gynecological surgery. PLoS One 2017;12(4):e0175875. DOI: 10.1371/journal.pone.0175875

22. Kayser K., Zink S., Schneider T. et al. Benign metastasizing leiomyoma of the uterus: Documentation of clinical, immunohistochemical and lectin-histochemical data of ten cases. Virchows Arch 2000;437(3):284–92. DOI: 10.1007/s004280000207

23. Котив Х.Б., Хмелевская Е.М., Нюганен А.О. и др. Клинический случай: двустороннее поражение легких доброкачествен ной метастазирующей лейомиомой. M., 2025.

24. Rao A.V., Wilson J., Sylvester K. Pulmonary benign metastasizing leiomyoma following hysterectomy: A clinicopathologic correlation. J Thorac Oncol 2008;3(6):674–6. DOI: 10.1097/JTO.0b013e3181757a46

25. Koh D.M., Burn P.R., King D.M. Benign metastasizing leiomyoma with intracaval leiomyomatosis. Br J Radiol 2000;73(868):435–7. DOI: 10.1259/bjr.73.868.10844871

26. Takemura G., Takatsu Y., Kaitani K. et al. Metastasizing uterine leiomyoma. A case with cardiac and pulmonary metastasis. Pathol Res Pr 1996;192(6):622–9. DOI: 10.1016/S0344-0338(96)80116-6

27. Jo J.H., Lee J.H., Kim D.C. et al. A case of benign metastasizing leiomyoma with multiple metastasis to the soft tissue, skeletal muscle, lung and breast. Korean J Intern Med 2006;21(3):199–201. DOI: 10.3904/kjim.2006.21.3.199

28. Mauduit M., Langouet Q., Rouzé S. et al. Post-menopausal pulmonary leiomyoma metastasis: An unexpected finding. Indian J Thorac Cardiovasc Surg 2018;34(4):513–5. DOI: 10.1007/s12055-018-0676-5

29. Huang L., Shi G., Wang Q. et al. Pulmonary and mediastinum metastasis of uterine leiomyoma: A case report. Med Baltim 2019;98(49):e18276. DOI: 10.1097/MD.0000000000018276

30. Yoon G., Kim T.J., Sung C.O. et al. Benign metastasizing leiomyoma with multiple lymph node metastasis: A case report. Cancer Res Treat 2011;43(2):131–3. DOI: 10.4143/crt.2011.43.2.131

31. André D., Gouveia F., Luís H. et al. Benign metastasizing leiomyoma – a case of benign metastasis. JRSM Open 2021. DOI: 10.1177/20542704211064482

32. Consamus E.N., Reardon M.J., Ayala A.G. et al. Metastasizing leiomyoma to heart. Methodist Debakey Cardiovasc J 2014;10(4):251–4. DOI: 10.14797/mdcj-10-4-251

33. Meddeb M., Chow R.D., Whipps R., Haque R. The heart as a site of metastasis of benign metastasizing leiomyoma: Case report and review of the literature. Case Rep Cardiol 2018. DOI: 10.1155/2018/7231326

34. Reis Soares R., Ferber Drumond L., Soares da Mata D. et al. Cardiac metastasizing leiomyoma: A case report. Int J Surg Case Rep 2020;7:647–50. DOI: 10.1016/j.ijscr.2020.11.095

35. Efared B., Atsame-Ebang G., Sani R. et al. Unexpected pulmonary tumor: Metastasis from a benign uterine leiomyoma in a post menopausal woman. A case report. BMC Res Notes 2017;10(1):662. DOI: 10.1186/s13104-017-2998-6

36. Ferreira A., Malheiro M., Martins A. Spinal cord compression secondary to benign metastasizing leiomyoma. Cureus 2022;14(2):e21845. DOI: 10.7759/cureus.21845

37. Otsuka S., Yanazume S., Mizuno M. et al. Metastatic leiomyoma following menopause: A case report and review of literature. Cureus 2022;14(11):e31549. DOI: 10.7759/cureus.31549

38. Karnib M., Rhea I., Elliott R. et al. Benign metastasizing leiomyoma in the heart of a 45-year-old woman. Tex Heart Inst J 2021;48(1):e197066. DOI: 10.14503/THIJ-19-7066

39. Khan M., Faisal A., Ibrahim H. et al. Pulmonary benign metastasizing leiomyoma: A case report. Respir Med Case Rep 2018;24:117–21. DOI: 10.1016/j.rmcr.2018.04.017

40. Choe Y.H., Jeon S.Y., Lee Y.C. et al. Benign metastasizing leiomyoma presenting as multiple cystic pulmonary nodules: A case report. BMC Women Health 2017;17(1):81. DOI: 10.1186/s12905-017-0435-6

41. Kang M.W., Kang S.K., Yu J.H. et al. Benign metastasizing leiomyoma: Metastasis to rib and vertebra. Ann Thorac Surg 2011;91(3):924–6. DOI: 10.1016/j.athoracsur.2010.08.030

42. Berti A.F., Santillan A., Velasquez L.A. Benign metastasizing leiomyoma of the cervical spine 31 years after uterine leiomyoma resection. J Clin Neurosci 2015;22(9):1491–2. DOI: 10.1016/j.jocn.2015.02.031

43. Awonuga A.O., Shavell V.I., Imudia A.N. et al. Pathogenesis of benign metastasizing leiomyoma: A review. Obstet Gynecol Surv 2010;6(3):189–95. DOI: 10.1097/OGX.0b013e3181d60f93

44. Kuo T., London S.N., Dinh T.V Endometriosis occurring in leiomyomatosis peritonealis disseminata: Ultrastructural study and histogenetic consideration. Am J Surg Pathol 1980;4(2): 197–204. DOI: 10.1097/00000478-198004000-00012

45. Hoetzenecker K., Ankersmit H.J., Aigner C. et al. Consequences of a wait-and-see strategy for benign metastasizing leiomyomatosis of the lung. Ann Thorac Surg 2009;87:613–4. DOI: 10.1016/j.athoracsur.2008.06.052

46. Hague W.M., Abdulwahid N.A., Jacobs H.S., Craft I. Use of LHRH analogue to obtain reversible castration in a patient with benign metastasizing leiomyoma. Br J Obstet Gynaecol 1986;93(5):455–60.

47. Cohen J.D., Robins H.I. Response of “benign” metastasizing leiomyoma to progestin withdrawal. Case report. Eur J Gynaecol Oncol 1993;14:44, 45.

48. Motegi M., Takayanagi N., Sando Y. et al A case of so-called benign metastasizing leiomyoma responsive to progesterone. Nihon Kyobu Shikkan Gakkai Zasshi 1993;31:890–5.

49. Ando H., Kusunoki S., Ota T. et al. Long-term efficacy and safety of aromatase inhibitor use for leiomyomatosis peritonealis disseminata. J Obstet Gynaecol Res 2017;43(9):1489–92. DOI: 10.1111/jog.13376

50. Vilos G.A., Allaire C., Laberge P.Y., Leyland N. The management of uterine leiomyomas. J Obstet Gynaecol Can 2015;37(2):157–78.

51. Altinoz M.A., Ozpinar A., Elmaci I. Reproductive epidemiology of glial tumors may reveal novel treatments: High-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma. Neurosurg Rev 2018;173:20–30. DOI: 10.1007/s10143-018-0953-1

52. Jautzke G., Müller-Ruchholtz E., Thalmann U. Immunohistological detection of estrogen and progesterone receptors in multiple and well differentiated leiomyomatous lung tumors in women with uterine leiomyomas (so-called benign metastasizing leiomyomas). A report on 5 cases. Pathol Res Pr 1996;192(3):215–23. DOI: 10.1016/S0344-0338(96)80224-X

53. Lewis E.I., Chason R.J., DeCherney A.H. et al. Novel hormone treatment of benign metastasizing leiomyoma: An analysis of five cases and literature review. Fertil Steril 2013;99(7):2017–24. DOI: 10.1016/j.fertnstert.2013.01.147

54. Safrai M., Chill H.H., Reuveni Salzman A., Shushan A. Selective progesterone receptor modulators for the treatment of uterine leiomyomas. Obstet Gynecol 2017;130(2):315–8. DOI: 10.1097/AOG.0000000000002143

55. Reis F.M., Bloise E., Ortiga-Carvalho T.M. Hormones and pathogenesis of uterine fibroids. Best Pr Res Clin Obstet Gynaecol 2016;34:13–24. DOI: 10.1016/j.bpobgyn.2015.11.015

56. Kortekaas K.E., Pelikan H.M.P. Non-surgical intervention for retroperitoneal lymphogenic and pulmonary metastases of a benign leiomyoma: Treatment with ulipristal acetate. BMJ Case Rep 2018;2018:bcr2017222693. DOI: 10.1136/bcr-2017-222693

57. Jiang J., He M., Hu X. et al. Deep sequencing reveals the molecular pathology characteristics between primary uterine leiomyoma and pulmonary benign metastasizing leiomyoma. Clin Transl Oncol 2018;20(8):1080–6. DOI: 10.1007/s12094-018-1847-y

58. Ottlakan A., Borda B., Lazar G. et al. Treatment decision based on the biological behavior of pulmonary benign metastasizing leiomyoma. J Thorac Dis 2016;8(8):E672–6. DOI: 10.21037/jtd.2016.06.61